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Abstract
Introduction: Despite high technical success of rescue Percutaneous Coronary 
Intervention (PCI) and also its significant impact on left ventricular function, the 
therapeutic outcome of this PCI technique in comparison with primary PCI for coronary 
reperfusion has remained uncertain. The present study aimed to conduct a comparative 
analysis of early and long-term results of patients with ST-Elevation Myocardial Infarction 
(STEMI), who had undergone primary or rescue PCI.
Methods: One hundred and twenty-nine consecutive patients with the diagnosis of 
STEMI, who underwent primary PCI (n = 107) or rescue PCI (n = 22) from April 2012 
to September 2013 were retrospectively included. In addition to early assessment of 
procedural consequences, the patients were followed-up to assess and compare long-term 
mortality and major adverse cardiovascular events. 
Results: Comparing in-hospital consequences of the two rescue PCI and primary PCI 
procedures showed no significant differences in in-hospital mortality (9.5% vs. 3.7%, P 
= 0.255), total hospital stay (6.32 ± 2.24 days vs. 6.61 ± 3.43 days, P = 0.720) and also in 
early procedural complications. Long-term death was found only in 1.9% of patients in the 
primary group and none of the patients in the rescue group (P = 0.999). There was also no 
difference in the prevalence of late stent thrombosis between the two groups. However, the 
in-hospital Left Ventricular Ejection Fraction (LVEF) was lower in the rescue PCI group 
vs. primary PCI group (36.82 ± 11.19 vs. 43.48 ± 9.14, P = 0.014), but after six months, 
LVEF was similar between the two groups (41.05 ± 9.57 vs. 44.29 ± 10.35, P = 0.082).
Conclusions: Our study showed no difference in early and late procedural outcome 
between the primary and rescue PCI techniques in STEMI patients, but LVEF had better 
improvement in the rescue PCI group.










Int J Cardiovasc Pract. 




Fibrinolytic therapy is a standard treatment for establishing 
myocardial reperfusion following acute ST-Elevation Myocar-
dial Infarction (STEMI) [1]. However, the application of this 
treatment option is limited by some potential contraindications 
including intracranial bleeding, re-occlusion, and recurrent 
ischemic events [2, 3]. In this regard, most cardiologists pre-
fer to the use of Primary Percutaneous Coronary Intervention 
(PCI) as the main therapeutic strategy for STEMI. Applying 
primary PCI has led to achieve a coronary artery TIMI-3 flow of 
higher than 90% leading to lower rates of recurrent ischemia and 
occlusion, higher patency, lower incidence of re-infarction and 
stroke as well as lower mortality rate in the long-term follow-up 
assessment in comparison with fibrinolytic therapy [4-6]. In 
total, primary PCI is strongly recommended for patients with 
STEMI that initially refer to emergency wards and need a rapid 
clinical intervention [7-9]. According to new recommendations 
released by the European Society of Cardiology and American 
College of Cardiology guidelines for the management of acute 
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myocardial infarction, in patients presenting STEMI faced with 
failed fibrinolysis, or with the presence of some evidences on 
re-infarction or coronary artery re-occlusion, immediate angi-
ography and rescue PCI should be considered [1]. Despite high 
technical success of rescue PCI and also its significant impact 
on left ventricular function, recent studies revealed high mor-
tality rate and also high re-occlusion rate related to this proce-
dure if unsuccessful [10]. Also, the appropriate outcome of this 
treatment option can be achieved in case of prompt recognition 
of failed fibrinolysis and also rapid transfer of the patient to the 
catheterization lab [11].
Despite identified clinical benefits of rescue PCI in failed fibri-
nolytic conditions, the clinical early and long-term consequenc-
es of this procedure particularly in comparison with primary 
PCI is still controversial. In fact, primary PCI has been consid-
ered as the gold standard, but the therapeutic state of rescue PCI 
for coronary reperfusion has remained uncertain [8-10, 12]. 
Hence, the present study aimed to conduct a comparative anal-
ysis of early and long-term results from patients with STEMI, 
who had undergone primary or rescue PCI to highlight the 
therapeutic role of rescue PCI in comparison with primary PCI.
METHODS
In a comparative study, 129 consecutive patients with the di-
agnosis of STEMI that received fibrinolytic therapy in other 
centers and referred to our hospital to undergo rescue PCI, or 
candidate for primary PCI at our center from April 2012 to Sep-
tember 2013, were assessed. The study protocol was approved 
by the board review of the cardiovascular research center. All 
the information was collected by reviewing the hospital record-
ed files including gender, age, cardiovascular risk factors (family 
history of Coronary Artery Disease (CAD), hypertension, hy-
perlipidemia, diabetes mellitus, current smoking, recent myo-
cardial infarction, and renal failure), history of revascularization 
by Coronary Artery Bypass Graft (CABG) or PCI, oral med-
ications, laboratory parameters, level of cardiac enzymes on 
admission, electrocardiography findings, results of angiography 
reports including number and types of diseased coronary ves-
sels, and echocardiography parameters such as left ventricular 
diameters and ejection fraction. In the rescue group, patients 
were previously treated with fibrinolytic agents and underwent 
rescue PCI based on the discretion of the clinician, during the 
first 24 hours of the acute event. The study endpoint was first 
to compare in-hospital mortality, length of hospital stay, and 
Major Adverse Cardiovascular Events (MACE) that occurred 
within hospitalization including minor or major bleeding, need 
of blood transfusion, hematoma, stent thrombosis, and chang-
es in left ventricular function level based on echocardiography 
assessment before discharge. Then, to assess the long-term effi-
cacy of the two procedures, the patients were followed-up with 
a mean follow-up time of six months to assess and compare late 
Left Ventricular Ejection Fraction (LVEF), long-term mortality 
and MACE, defined as repeated coronary angiography, CABG, 
or PCI or occurrence of ischemic cardiovascular or cerebrovas-
cular accidents.
For statistical analysis, results were presented as mean ± Stan-
dard Deviation (SD) for quantitative variables and were sum-
marized by frequencies (percentages) for categorical variables. 
Continuous variables were compared using the t test. Non-para-
metric Mann-Whitney test was used whenever the data did not 
appear to have normal distribution or when the assumption 
of equal variances was violated across the study groups. Cat-
egorical variables were, on the other hand, compared using 
chi-square test. Change in study parameters was assessed using 
paired t test or McNamara test. The multivariate cox propor-
tional hazard modeling was used to assess the differences in 
study outcomes between primary and rescue PCI groups with 
the presence of baseline variables as the confounders. For the 
statistical analysis, the SPSS statistical software version 21.0 for 
windows (SPSS Inc., Chicago, IL) was used. P values of 0.05 or 
less were considered statistically significant.
RESULTS
Baseline characteristics: In total, 129 patients were assessed re-
garding baseline characteristics as well as early and long-term 
outcome of PCI procedure, where 22 underwent rescue PCI 
and 107 underwent primary PCI. The average age of the par-
ticipants was 55.64 ± 11.00 years and 57.04 ± 10.90 years (P 
= 0.119) in the rescue PCI and primary PCI group, respective-
ly. Also, with regards to gender distribution, 95.5% and 82.2% 
were male, respectively (P = 0.358). The two groups were sim-
ilar in terms of the prevalence of cardiovascular risk factors, 
history of oral medications, and level of baseline laboratory 
parameters (Table 1). With regards to baseline ECG pattern, in-
ferior MI was found in 27.3% and 24.8%, anterior MI in 27.3% 
and 22.9%, and extensive MI in 18.2% and 13.3%, in the rescue 
PCI and primary PCI group, respectively, with no difference in 
overall ECG patterns. Also, no difference was revealed in the 
number of involved coronary vessels, where single, two, and 
three-coronary involvement was found in 45.5%, 50.0% and 
4.5% in the rescue group and 43.9%, 36.4%, and 19.6% in the 
primary PCI group, respectively. There were also no differences 
between the two groups in the type and number of used stents, 
but the mean left ventricular ejection fraction was significantly 
lower in the rescue PCI group (Table 2).
In-hospital outcome: Comparing in-hospital consequences 
of the two rescue PCI and primary PCI procedures (Table 3) 
showed no significant differences in in-hospital mortality (9.5% 
vs. 3.7%, P = 0.255), total hospital stay (6.32 ± 2.24 days vs. 6.61 
±3.43 days, P = 0.720) and also in early procedural complica-
tions including minor local bleeding, hematoma, gastrointesti-
nal bleeding and post-catheterization hemodynamic status. Re-
garding TIMI flow grading before discharge, TIMI flow grade 3 
was found in 87.5% in the rescue PCI group and 98.5% in the 
primary PCI group with no difference (P = 0.869).
Late outcome: Long-term death was found only in 1.9% of pa-
tients in the primary group and none of the patients in the res-
cue group (P = 0.999). Also, none of the cases underwent late 
CABG after the initial rescue group and only one patient in the 
primary PCI group underwent CABG. There was also no dif-
ference in the prevalence of late stent thrombosis between the 
two groups. However, the greater need for repeat angiography 
and PCI was found in patients of the primary PCI group, after 
initial treatment with PCI (Table 4). Using cox proportional 
hazard analysis and with the presence of baseline variables (Ta-
ble 5), although the need for coronary angiography and repeat 
PCI was univariately more frequent in primary PCI group than 
in rescue PCI group, but need for late PCI was independent 
to the type of PCI procedure in multivariable analysis. In this 
regard, the number of involved coronary vessels was the only 
main predictor of the requirement for repeat PCI in the study 
population. Late LVEF was similar between rescue and primary 
PCI group after six months (41.05 ± 9.57 vs. 44.29 ± 10.35, re-
spectively; P = 0.082).
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Table 1: Baseline Characteristics and Clinical Data in Primary PCI and Rescue PCI Groups
Characteristics Rescue PCI Group, (n = 22) Primary PCI Group, (n = 107) P value
Male gender 21 (95.5) 88 (82.2) 0.119
Age, year 55.64 ± 11.00 58.04 ± 10.90 0.358
 Hypertension 10 (45.5) 35 (32.7) 0.253
Diabetes mellitus 5 (22.7) 29 (27.1) 0.671
 Dyslipidemia 9 (40.9) 40 (37.4) 0.756
Renal failure 1 (4.5) 2 (1.9) 0.432
Family history of CAD 8 (36.4) 25 (23.4) 0.203
Cigarette smoking 11 (50.0) 52 (48.6) 0.905
Opium use 4 (18.2) 12 (11.2) 0.367
Previous MI 0 (0.0) 2 (1.9) 0.999
Previous PCI 1 (4.5) 7 (6.6) 0.717
 Aspirin use 4 (18.2) 14 (13.1) 0.530
Plavix use 0 (0.0) 2 (1.9) 0.999
Beta-blocker use 2 (9.1) 14 (13.2) 0.737
 Statin use 0 (0.0) 8 (7.5) 0.349
ACE-inhibitor use 4 (18.2) 6 (5.7) 0.069
Hemoglobin, mg/dl 14.73 ± 1.45 14.02 ± 1.94 0.108
Creatinine, mg/dl 1.19 ± 0.25 1.12 ± 0.23 0.239
Platelet, /mm3 × 1000 242.00 ± 56.33 241.27 ± 78.32 0.959
Cholesterol, mg/dl 184.73 ± 55.25 181.52 ± 42.45 0.800
HDL, mg/dl 39.95 ± 13.59 40.30 ± 9.55 0.912
Triglyceride, mg/dl 197.59 ± 96.49 137.37 ± 95.04 0.214
LDL, mg/dl 104.50 ± 36.50 110.72 ± 33.88 0.469
Fasting blood sugar, mg/dl 149.26 ± 63.27 151.01 ± 57.24 0.912
Troponin T 15.48 ± 15.90 11.76 ± 17.53 0.422
Data in table are presented as No. (%) or Mean ± SD.
 CAD: Coronary artery disease; MI: Myocardial infarction; PCI: Percutaneous coronary intervention; ACE: Angiotensin converting
enzyme; HDL: High-density lipoprotein; LDL: Low-density lipoprotein.
Table 2: Baseline Cardiovascular Status in Primary PCI and Rescue PCI Groups
 Characteristics Rescue PCI Group, (n = 22) Primary PCI Group, (n = 107) P value
Intra-aortic balloon pump use 1 (4.5) 7 (6.5) 0.724
ECG pattern
Inferior MI 6 (27.3) 26 (24.8) 0.821
Anterior MI 6 (27.3) 24 (22.9) 0.703
Anteroseptal MI 2 (9.1) 10 (9.5) 0.999
Lateral MI 1 (4.5) 5 (4.8) 0.999
Extensive MI 4 (18.2) 14 (13.3) 0.527
RV-inferior MI 2 (9.1) 24 (22.9) 0.372
Inferoposterior MI 1 (4.5) 0 (0.0) 0.999
Number of diseased vessels
Single-vessel disease 10 (45.5) 47 (43.9) 0.935
Two-vessel disease 11 (50.0) 39 (36.4) 0.444
Three-vessel disease 1 (4.5) 21 (19.6) 0.200
Infarcted vessel
LAD 12 (54.5) 50 (46.7) 0.697
LCX 1 (4.5) 14 (13.1) 0.466
RCA 9 (40.9) 43 (40.2) 0.967
Type of stent
BMS 20 (93.8) 82 (77.0) 0.617
DES 2 (6.2) 15 (23.0) 0.739
 Number of stents
1 16 (75.0) 81 (75.8) 0.911
2 3 (12.5) 20 (19.2) 0.768
3 3 (12.5) 6 (5.1) 0.208
LVEF (angiography) 36.82 ± 11.19 43.48 ± 9.14 0.014
Data in table are presented as No. (%) or Mean ± SD.
 MI: Myocardial infarction; LAD: Left anterior descending; LCX: Left circumflex; RCA: Right coronary artery; BMS: Bare metal stent;
DES: Drug eluting stent; LVEF: Left ventricular ejection fraction.
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Table 3: In-hospital Outcome of Procedure in Primary PCI and Rescue PCI Groups
 Characteristics Rescue PCI Group, (n = 22) Primary PCI Group, (n = 107) P value
In-hospital mortality 2 (9.5) 4 (3.7) 0.255
 Minor bleeding 1 (4.8) 4 (3.8) 0.832
 Hematoma 0 (0.0) 4 (3.8) 0.999
Gastrointestinal bleeding 2 (9.5) 3 (2.8) 0.191
Post-catheterization blood pressure 118.05 ± 9.07 120.48 ± 21.83 0.610
Post-catheterization heart rate, /min 85.18 ± 18.21 81.49 ± 17.29 0.390
Length of stay in hospital, day 6.32 ± 2.24 6.61 ± 3.43 0.720
TIMI flow grade before discharge
0 2 (12.5) 0 (0.0) 0.092
1 0 (0.0) 1 (1.4) 0.999
3 14 (87.5) 64 (98.5) 0.869
Data in table are presented as No. (%) or Mean ± SD.
TIMI: Thrombolysis in myocardial infarction.
Table 4: Long-term Outcome of Procedure in Primary PCI and Rescue PCI Groups
Characteristics Rescue PCI Group, (n = 22) Primary PCI Group, (n = 107) P value
Long-term death 0 (0.0) 2 (1.9) 0.999
Repeated angiography 0 (0.0) 20 (18.9) 0.023
Repeated PCI 0 (0.0) 16 (15.1) 0.047
CABG procedure 0 (0.0) 1 (0.9) 0.999
Stent thrombosis 0 (0.0) 1 (0.9) 0.999
Long-term LVEF 41.05 ± 9.57 44.29 ± 10.35 0.082
Mean number of admission 0.05 ± 0.21 0.19 ± 0.62 0.291
Data in table are presented as No. (%) or Mean ± SD.
PCI: Percutaneous coronary intervention; CABG: Coronary artery bypass graft; LVEF: Left ventricular ejection fraction.
Table 5: Main Determinants of Repeated PCI Following First PCI
Variable Beta SE Wald P value Hazard Ratio
Rescue vs. primary PCI 13.201 621.681 0.000 0.983 5.407
Male gender -0.573 1.375 0.174 0.677 0.564
Age -0.005 0.041 0.015 0.901 0.995
Hypertension -0.967 1.395 0.481 0.488 0.380
Diabetes mellitus 0.997 1.327 0.564 0.453 2.711
 Dyslipidemia -0.571 0.946 0.363 0.547 0.565
Family history of CAD 10.461 1.210 1.456 0.228 4.309
Smoking 0.448 0.973 0.212 0.645 1.566
Opium use 0.642 1.242 0.267 0.605 1.900
Intra-aortic balloon pump 0.313 1.929 0.026 0.871 1.367
Number of diseased vessels 1.613 0.715 5.088 0.024 5.016
Infarcted vessel 0.431 0.499 0.744 0.388 1.538
First TIMI flow grade -1.165 1.207 0.931 0.335 0.312
Aspirin use -1.885 1.433 1.729 0.189 0.152
Beta-blocker use 3.062 2.333 1.724 0.189 21.379
ACE-inhibitor use -0.331 1.848 0.032 0.858 0.718
Drug eluting stent use -1.439 1.241 1.346 0.246 0.237
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DISCUSSION
Rescue PCI remains an infrequent procedure in various data 
registry analysis because many clinicians do not assess the 
success of reperfusion in patients with STEMI, who receive 
thrombolytic analysis, and only a minority are candidates for 
rescue PCI due to failed fibrinolysis [13]. As shown in our 
survey, most CAD patients requiring percutaneous interven-
tions underwent primary PCI; only 17% of the study patients 
had rescue PCI because of thrombolysis failure. However, 
some researches have emphasized on the greater effectiveness 
of rescue PCI compared to primary PCI, while some others 
discuss the early and long-term consequences following pri-
mary PCI when compared to rescue PCI [14-16]. In our 
observation, both early and late outcome of the two proce-
dures were assessed and compared. We first achieved a base-
line balance between the baseline variables including demo-
graphics, cardiovascular risk factors, medications, and even 
cardiovascular functional state between primary PCI and 
rescue PCI groups. Also, in-hospital mortality, hospital stay 
and early post-procedural adverse events occurred at similar 
rates. Moreover, in the long-term follow-up, no differences 
were found in mortality, late stent thrombosis, and require-
ment for CABG between the two groups, however the need 
for repeat PCI was more prevalent in the primary PCI group. 
Despite this finding, multivariate hazard analysis could not 
demonstrate a difference in the requirement for repeat PCI 
in the primary PCI group compared to the rescue PCI group. 
In fact, the main predictor for greater need for repeat PCI was 
higher number of diseased coronary vessels, not the type of 
PCI procedure.
Former clinical trials and series reported contradictory re-
sults in early and late outcome of rescue PCI and primary 
PCI. In a study by Gao and colleagues [14], post-procedural 
patency rate and TIMI flow grade 3 were lower in the rescue 
PCI than in the primary PCI group. Also, in thirty-day fol-
low-up, mortality rate and rates of myocardial infarction and 
bleeding complications was higher in the rescue PCI when 
compared to primary PCI. Contrary to these findings, Re-
buzzi et al. [15] showed lowering rate of heart failure and in-
creasing one-year survival after rescue PCI. Gimelli et al. [16] 
also showed higher rates of six-month morbidity defined as 
the occurrence of at least one of the events of death, recurrent 
MI, repeat PCI, CABG and recurrent angina in the primary 
group compared to the rescue group, yet this difference was 
not statistically significant. In our observation, although re-
peat PCI occurred more in the long-term in the primary PCI 
group than in the rescue PCI group in univariate analysis, 
yet this difference was not observed using cox-proportional 
hazard modeling. On the other hand, there was no difference 
in long-term mortality and morbidity between the two PCI 
procedures.
In our study, the number of diseased coronary vessels and 
thus the number of used stents was only a predictor for PCI 
requirement following initial PCI procedure. In fact, our 
study identified CAD severity and therefore the need for 
more stent implantations as a main determinant for stent rest-
enosis leading to a repeat PCI procedure. In a study which 
compared the outcome of PCI between youth and elderly, 
predictors for long-term MACE included multi-vessel coro-
nary disease along with advanced age, occurrence of throm-
bolysis, and cardiogenic shock [17]. Although various stud-
ies have emphasized both patient-related factors (especially 
medications, diabetes and other inflammatory-based disease 
conditions) and procedural variables (such as size of stents 
and multiple stents), in our study, none of the baseline char-
acteristics including the type of used drugs, type of applied 
stent, and also cardiovascular risk factors could predict late 
stent restenosis requiring repeat PCI. In fact, multiple stent-
ing due to multi-vessel involvement can be a potential predic-
tor for requiring repeat PCI.
We concluded from the current comparative analysis be-
tween the two rescue and primary PCI procedures in STEMI 
patients that no difference was observable in both in-hospital 
and long-term mortality and complications. However, the 
LVEF was lower in rescue PCI group than the primary PCI 
group during admission, but in late follow-up, it was similar 
between these two groups. This means that left ventricular 
function improved more in patients who underwent rescue 
PCI not primary PCI.
Limitations of the Study
Limitations of this study were small number of participants, 
thus the findings should be used with care and, further stud-
ies need to be accomplished to confirm the results.
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